Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | - CEO | XSHE Exchange | CNE000000VV8 ISIN |
China Country | 1,002 Employees | - Last Dividend | 24 May 2017 Last Split | - IPO Date |
Dezhan Healthcare Company Limited is a prominent entity in the pharmaceutical industry of the People's Republic of China, focusing on the research and development, manufacturing, and distribution of a wide variety of drugs primarily aimed at treating cardiovascular and cerebrovascular diseases. Since its establishment in 1980, the company has committed itself to producing high-quality medications to meet the health needs of the population and has significantly expanded its product line to include not only pharmaceuticals but also biological peptide products, food and beverages, cosmetics, and other health-related goods. Headquartered in Beijing, Dezhan Healthcare continues to innovate in the healthcare sector, contributing substantially to the local market with its vast array of products and services.
The diverse product range of Dezhan Healthcare encompasses several key areas within the pharmaceutical sector, embodying the company's dedication to heart and brain health, among other specialties. Below is an overview of their prominent offerings:
In addition to pharmaceuticals, Dezhan Healthcare is actively involved in producing biological peptide products, further emphasizing its focus on innovative healthcare solutions. The company also diversifies its offerings into the food and beverage sector, cosmetics, and other health and wellness products, portraying a holistic approach to healthcare. Each product and service is a testament to Dezhan Healthcare's dedication to improving health outcomes and quality of life for individuals across the People's Republic of China.